Misof, Barbara M <br/><br/>
Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Mar 2013 
 - 442-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1002/jbmr.1780  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biopsy<br/>Bone Density<br/>Bone Density Conservation Agents--administration & dosage<br/>Cohort Studies<br/>Diphosphonates--administration & dosage<br/>Humans<br/>Imidazoles--administration & dosage<br/>Infusions, Intravenous<br/>Placebos<br/>Zoledronic Acid